What is Wasatch Therapy?
Wasatch Therapy operates as a specialized outpatient clinic provider, distinguishing itself through a comprehensive suite of orthopedic, lymphedema, and pelvic health services. By integrating cutting-edge modalities such as SoftWave therapy, the company addresses complex patient needs with high-precision, evidence-based care. The firm's market position is defined by its commitment to personalized recovery pathways, effectively bridging the gap between traditional physical therapy and advanced medical technology. As a key player in the regional healthcare landscape, Wasatch Therapy leverages its clinical expertise to drive patient outcomes, positioning itself as a preferred partner for individuals navigating intricate recovery journeys.
How much funding has Wasatch Therapy raised?
Wasatch Therapy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Wasatch Therapy
PPP
Public-Private Partnership
What's next for Wasatch Therapy?
The infusion of capital is expected to catalyze the next phase of growth for Wasatch Therapy, likely focusing on the expansion of its clinical footprint and the further integration of proprietary therapeutic technologies. Given the late-stage nature of this financing, the organization is well-positioned to optimize its operational efficiencies and potentially explore strategic acquisitions or service line diversification. By prioritizing the scalability of its personalized treatment models, Wasatch Therapy aims to capture a larger share of the outpatient rehabilitation market, ensuring long-term sustainability and continued excellence in patient-centric care. Future initiatives will likely center on enhancing digital health capabilities and expanding the reach of its specialized programs to meet rising demand for high-acuity physical therapy services.
See full Wasatch Therapy company page
